Menu
Not yet recruiting NCT07520461

Microbiome-targeted Diet Therapy in Ulcerative Colitis

No phase Interventional Ulcerative Colitis

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: High Protein, High Fiber (HPHF) Diet.
Who it may be relevant to
Registry conditions: Ulcerative Colitis. Basic parameters: from 18 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
Center list to be confirmed — check the primary protocol.
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →

Overview

The central objective of this proposal is to test a novel diet capable of meeting the elevated protein requirements in ulcerative colitis (UC), while simultaneously decreasing microbial hydrogen sulfide (H2S) production in the colon with fiber.

Interventions

  • Other High Protein, High Fiber (HPHF) Diet
    The HPHF diet is a diet designed to maximize the intake of proteins and fermentable dietary fibers. Frozen meals are provided to participants weekly and consumed over two non-consecutive 7-day periods.

Primary outcome measures

  • Fecal H2S Production [Time frame: Week 4]

Eligibility criteria

Inclusion criteria

  • Ability and willingness to provide informed consent
  • Age at least 18 years old
  • Diagnosis of UC based on clinical and endoscopic criteria
  • UC duration of at least 3 months
  • Ulcerative Colitis Endoscopic Index of Severity (UCEIS) score ≤4 within 90 days of randomization
  • On a stable dose or no existing UC therapies (apart from steroids) for defined periods (as outlined below).
  • ≥4 weeks if no medication, 5-ASA
  • ≥8 wk for immunomodulatory therapy
  • ≥12 wk for biologics
  • Ability to comply with study requirements in the opinion of the primary investigator

Exclusion criteria

  • Moderate or severe UC as defined by UCEIS ≥5
  • History of stomach surgery or bowel resection
  • Antibiotic use within 3 months
  • Anticipated antibiotic exposure during the study period (e.g. perioperative antibiotics)
  • Pregnancy or breastfeeding
  • History of anaphylactic food allergies
  • Intolerance of high dietary fiber content
  • Ongoing alcohol or drug abuse
  • Habitual vegan diet pattern
  • Insufficient freezer space to accommodate meal delivery

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: No

Study design

Allocation
N/A
Model
Crossover
Masking
Open label
Primary purpose
Treatment

Study locations

Center list to be confirmed — check the primary protocol.

Identifiers

NCT: NCT07520461 · GI-2026-34620

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗